News

ReproUnion SUMMIT celebrates results in preventing and treating infertility and looks to the future!

ReproUnion SUMMIT celebrates results in preventing and treating infertility and looks to the future!

At the ReproUnion Summit on 2 September 2022, the public-private partnership celebrated a decade of multi-disciplinary collaboration to overcome infertility and took a future perspective to continue building the next generation of reproductive researchers, as well as to build capacity by supporting the scale up of innovative ideas in collaboration with start-ups and other companies in the field of reproduction.

High-level debate on Folkemødet: Involuntary childlessness steals dreams – and labour!

High-level debate on Folkemødet: Involuntary childlessness steals dreams – and labour!

On 16-19 June 2022 close to 100.000 people stopped by Folkemødet – the Danish democracy festival with 2500 debates and events! In a fully packed tent Søren Ziebe sat the scene for an engaging panel discussion on the topic: Involuntary childlessness steals dreams – and labour! Moderator Peter Qvortrup Geisling secured a very engaging debate and involvement from the audience!

A successful 5th ReproYoung conference attracts new members to the network

A successful 5th ReproYoung conference attracts new members to the network

Close to 100 delegates participated in the conference with symposia, poster walks and a battle-style debate between Principal Investigators in different disciplines of reproductive medicine. There was plenty of airtime for young researchers as well as excellent networking and the sharing of knowledge and the conference turned out as a great showcase to attract new members to ReproYoung!

Anja Pinborg calls for careful interpretation of a US study suggesting pregnancy complications are more likely after ART

Anja Pinborg calls for careful interpretation of a US study suggesting pregnancy complications are more likely after ART

The study associates assisted reproduction with an increased risk of complications during pregnancy, especially in women aged 35 years or older and those with pre-existing health problems. However, participants in the study were pooled into one group, not distinguishing between different fertility treatments and the techniques used nor between singletons and twin births.